chrisvoncsefalvay/vaers-outcomes huggingface dataset:
vision is still "iffy"; irritation; shingles on the forehead and around the eye; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (shingles on the forehead and around the eye), VISUAL IMPAIRMENT (vision is still "iffy") and SKIN IRRITATION (irritation) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No history provided by Reporter.  Concurrent medical conditions included Penicillin allergy, Drug allergy (sulfa drug allergy) and Drug allergy (Allergy to most of the pain medications). Concomitant products included SIMVASTATIN and LISINOPRIL for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced HERPES ZOSTER (shingles on the forehead and around the eye). On an unknown date, the patient experienced VISUAL IMPAIRMENT (vision is still "iffy") and SKIN IRRITATION (irritation). At the time of the report, HERPES ZOSTER (shingles on the forehead and around the eye) had not resolved and VISUAL IMPAIRMENT (vision is still "iffy") and SKIN IRRITATION (irritation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided by Reporter.   Reporter did not allow further contact.
No adverse affects reported; improperly stored VARIVAX was administered to patient on 5/5/2020; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, drug reactions, and allergies were not provided.  On 05-MAY-2020, the patient was vaccinated with an improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (vaccination scheme, anatomical location of injection and route of admininistration were not reported; lot number S012036, which has been verified to be valid, expiration date reported and validated as 17-APR-2021) as prophylaxis (product storage error). The vaccine underwent a temperature excursion of 48.2 degrees (scale not specified) for 4 hours. There was no previous temperature excursion, and a digital data logger was involved. No adverse effects reported.
Dose #1 received on 4/21/21. Dose #2 received on 5/12/21. Difficulty breathing beginning on 5/5/28/21.  Diagnosed with multiple blood clots in right lung on 5/30/21.
her mouth felt numb with a little of tin; she could not taste anything; Her tongue feels as if it is a burned, numbed tongue. sensation has not returned to her tongue; has burning mouth syndrome; symptoms have to be related to the nerves; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (her mouth felt numb with a little of tin), AGEUSIA (she could not taste anything), HYPOAESTHESIA ORAL (Her tongue feels as if it is a burned, numbed tongue. sensation has not returned to her tongue), BURNING MOUTH SYNDROME (has burning mouth syndrome) and FACIAL NERVE DISORDER (symptoms have to be related to the nerves) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 002A21A) for COVID-19 vaccination.     Concurrent medical conditions included Burning mouth syndrome, Sulfonamide allergy and Drug allergy. Concomitant products included VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced HYPOAESTHESIA ORAL (her mouth felt numb with a little of tin), AGEUSIA (she could not taste anything), HYPOAESTHESIA ORAL (Her tongue feels as if it is a burned, numbed tongue. sensation has not returned to her tongue), BURNING MOUTH SYNDROME (has burning mouth syndrome) and FACIAL NERVE DISORDER (symptoms have to be related to the nerves). At the time of the report, HYPOAESTHESIA ORAL (her mouth felt numb with a little of tin), AGEUSIA (she could not taste anything), HYPOAESTHESIA ORAL (Her tongue feels as if it is a burned, numbed tongue. sensation has not returned to her tongue), BURNING MOUTH SYNDROME (has burning mouth syndrome) and FACIAL NERVE DISORDER (symptoms have to be related to the nerves) outcome was unknown.            Vitamin D is used for low blood level.   No treatment was reported.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Patient demographics were updated. Second dose details were added. Concomitant medications were added.
allergic reaction; local reactions-erythema; swelling in the left leg; Initial information received on 07-Oct-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 5 years old male patient who experienced allergic reaction (hypersensitivity), local reactions-erythema (erythema) and swelling in the left leg (swelling), while he received vaccines HEPATITIS A and INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HEPATITIS A VACCINE (HEPATITIS A) for Immunisation.  On 04-Oct-2019, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED lot: UJ223AA, expiry date: 30-Jun-2020, via intramuscular route in the left thigh.  On an unknown date, the patient had allergic reaction (hypersensitivity), local reactions-erythema (erythema) and swelling in the left leg (swelling) (Unknown latency) following the administration of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED.  Lab data was not reported.  Final diagnosis was hypersensitivity, erythema and swelling.   It was not reported if the patient received a corrective treatment.  The patient outcome was reported as unknown for all the events.  List of document held by sender: none.
Local redness, swelling and tenderness x 8 cm, fever, myalgias, arthralgias all lasting over 48 hours following vaccine, still feels sick
Tingling in arm and then "feels like shingles in her mouth and all throughout her body".
she is in critical condition from high blood pressure; This is a spontaneous report from a non-contactable consumer (patient's son) Pfizer sponsored program. A female patient of unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; formulation: solution for injection; Lot Number: not reported, expiration date: not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. Medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 on an unspecified date as SINGLE for covid-19 immunization. Reporter stated, on an unspecified date, she is in critical condition from high blood pressure. Reporter also stated patient received both doses of the Pfizer Covid-19 vaccine. She now needs to be admitted to the hospital because she is in critical condition from high blood pressure. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.No further information is expected.
later that day blood pressure rose to 196/110/Again it Escalated the following day; body aches; headache; interment weakness; shaking in my arms; tingling sensation in my feet and lower legs; This is a spontaneous report from a contactable consumer (patient). A 58-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration administered in right arm on 14Mar2021 16:00 (Batch/Lot Number: EP6955) (at the age of 58-year-old) as DOSE 1, SINGLE for covid-19 immunisation. The patient was not diagnosed with covid-19 prior to vaccination. Medical history included allergies to Nyquil and wasp. Concomitant medications included ademetionine (SAM-E); colecalciferol (D3); elderberry [sambucus nigra]; and magnesium carbonate (MAG 2 [MAGNESIUM CARBONATE]). On 15Mar2021 at 05:00 PM, the patient experienced later that day blood pressure rose to 196/110, body aches, headache, interment weakness, "shaking in my arms," and "tingling sensation in my feet and lower legs." It was further reported that the blood pressure rose to 196/110 and came down that night and again it escalated the following day and went to emergency room (ER) and was treated with blood pressure medication. The events resulted in emergency room/department or urgent care. The patient underwent lab tests and procedures which included blood pressure increased: 196/110 mmhg on 15Mar2021 and sars-cov-2 test (nasal swab): negative on 16Mar2021. Therapeutic measures were taken as a result of all events. The patient had not yet recovered from all events.  Follow-up attempts are completed. No further information is expected.
About 3 hours after vaccination, pt got sick all of a sudden, vomiting, sweating, weak and swelling around the eyes and throat. She felt really cold, went to ER. for treatment. Fluids was given. Stayed at hospital til 2AM (approximately 6 hours). The next day, body hurt/sore from head to toe, possibly fever as well. Pt is feeling better now.
Dryness of eyes; Black prints on eyes; This is a spontaneous report from a contactable consumer. A 61-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 26Feb2021 06:15 (at the age of 61-year-old) (Batch/Lot number was not reported) as dose number unknown, single for covid-19 immunisation. Medical history included multiple issues following severe accident and known allergies: rubber. The patient's concomitant medications were not reported. The patient received any other medications within 2 weeks of vaccination but do know what. On an unspecified date, the patient experienced dryness of eyes and black prints on eyes. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for covid-19. Outcome of events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from an MA concerning a child who was vaccinated with MMRII. It was reported that a pt's mother knew a child who developed autism from "the mercury in MMRII". It was unknown if the child sought medical attention. The child's autism persisted. The pt's mother felt that the autism was related to the therapy with MMRII. Upon internal review, autism was determined to be an "Other Important Medical Event". Additional information is not expected. Follow-up info received indicated that the reporter's office did not know the child or the doctor who administered the vaccine because the child was a friend of one of their patients. Upon internal review, autism was determined to be an other medical event (OMIC). No further info is available.
This spontaneous report as received from a patient's wife refers to a 75 year old male patient with high blood pressure and no drug reactions or allergies. On 04-SEP-2012 the patient was vaccinated with ZOSTAVAX injection (route, strength, lot number and expiration date not provided). In October 2013 (reported as late October 2013) the patient developed shingles after getting ZOSTAVAX. He developed the rash on his left shoulder and then it advanced to his chest and back on the left side. At the time of report he still had tenderness in the muscles in that area (onset date of tenderness in the muscles was not reported). The patient saw the physician. For the treatment he was given an unspecified pain medication. No lab diagnostics studies were performed. The outcome of the patient's adverse events was reported as not recovered/not resolved. The relatedness between vaccination with ZOSTAVAX and the patient's adverse events was not reported. Additional information has been requested.
Worsening of nephrotic syndrome secondary to influenza vaccine. Pt has a history of nephrotic syndrome,most commonly associated with infections. Pt presented to hospital with weight gain, dropping albumin and fluid retention. Pt reported receiving an influenza vaccine at a remote clinic several weeks prior to admission.
Patient states Redness all the way around bottom of bra line chest area, up on left shoulder where bra strap is, some redness on right shoulder but worse on left shoulder.   patient states area was red and slick feeling, also  warm to touch.
Patient complaint: Since 7 Nov flu injection, has pain in R arm, states he's been sick since. Always gets sick when he get the injection. Went to ER states he was given some meds and sent home. Fingers numb, with burning.
Child received vaccines on 4/18/01 and on 4/24/01 AM, developed fever and then a seizure. Was taken to hospital by EMS and dx'd as probable febrile seizure. Thought to have viral illness. Still fever today.
Patient had soreness for 2 days after vaccination, then injection site felt a little warm, 4 days post injection developed hematoma. Patient went to Emergency Department 7 days post vaccination.
Patient's left thigh is red and bruised. Measured 8x10 cm, looks like a reaction to the vaccine. Mother put ice packs and administered Pain relief medication. Irritation and inflammation.
Severe muscular pain, body aches, lethargy, tingling in hands and feet. All of these symptoms came on suddenly within one weekend, symptoms have persisted. Rheumatologist diagnosed atypical fibromyalgia from this event. Neurologist suspects flu vaccine adverse reaction. No family history of fibromyalgia.
At 11:15 PM, I suddenly felt faint, weak and very warm and I became very pale.  I laid in bed with a/c on and cold cloth on my forehead and symptoms passed after about 15 minutes and I dozed off.
after injection pt had seizure like episode (blacked out, rigid body) - came back  quickly within 30 seconds or so- but went into shock- low bp, white palor, nausea, sweating, altered consciousness- which lasted about 10-15 minutes before maintaining a steady status-
1st vaccine mild sore 2 days  2nd vaccine slight temp 99.7 f, sore arm and now still sore in upper shoulder to shoulder blade  Not seen by PCP or walk in.   Pt took Ibuprofen 400 mg as needed, relief is noted. suggested if irritation persists to follow-up with PCP or urgent care suggested to take ibuprofen as needed as recommended.  1st lot # 011L20A       2nd lot # 012M20A 2nd 1/28/21 1000 hr.  1st vacciner 12/31/20 at     Facility name where the vaccine was given: 1st DOH    2nd vaccine
p/recv vax pt described burning, itching, swelling. arm became edematous to just below elbow & to be cellulitis. given antibiotics
Nausea, diarrhea, migraine, extreme fatigue, weakness, POTS, Small fiber neuropathy, confusion, seizure,  etc
no adverse effect; 28 week pregnant patient was vaccinated with MMR II and Gardasil 9; This spontaneous retrospective pregnancy report was received from a nurse regarding a female patient of unknown age. The patient's concurrent condition, pertinent medical history, concomitant therapies and drug reactions/allergies were unknown. The patient became pregnant with Last Menstrual Period (LMP) of 23-APR-2016. The date of conception was on 07-MAY-2016. On 05-NOV-2016, at 28 weeks of gestation, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II); hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (dose, frequency, route of administration, anatomical location, lot # and expiration date were unknown) for prophylaxis (Exposure during pregnancy). The Expected Delivery Date (EDD) was on 28-JAN-2017. The pregnancy outcome was unknown. The fetal outcome was unknown. No adverse effects were reported.
Patient received 2nd Moderna shot at 8:30 a.m. 4-21-21.  She waited time in the store and was fine to leave.  She called the pharmacy and spoke to the pharmacist.  She reported she had a red rash/spot on face.  Pharmacist told her to take benadryl and watch the spot for development.  If starting to have trouble breathing, go to ER, urgent care, or call 911.
Within minutes of getting the vaccine I was on the floor.  I was taken to the hospital and am still here.  I can't feel anything below my knees and have weekness in my hands.   I can't walk and have difficulty moving my legs.  Doctors are saying that they don't know if I will ever walk again.
I went to the clinic and when they checked my blood pressure, it was high. When I went for my physical, I mentioned that to my physician and she asked if I had any other symptoms. The only symptom was just showing of a high blood pressure. It was checked twice at my physical appointment, and we decided it was best to start a blood pressure medication to reduce it. The medication prescribed was labetalol.
Within 2 min after HPV given nauseated, dizzy, clammy. Stood up walked into next rm passed out before getting onto bed. Out for 2-3 min. Layed on bed for 10 min then sat up and ate crackers & water.
Immediately after showed signs of listlessness throughout the rest of the day into the night. The following 3 days had uncontrollable crying and fussiness. Also came down with rash on face.
Got vaccine at 12:30 PM....arrived home started inputting info (1:30PM) into home computer and got very tired and sleepy, had to fight to stay awake. Took blood pressure at 1:30 PM (78/44).  Morning BP was 98/54 at 9:38 AM.  Checked blood pressure an hour later (98/48) and felt much better but still a little tired.  Blood pressure average for the week prior was around 112/58. My heart function is low, between 20-25%. and BP is usually in 112/58 range.
Rash and Swelling at site of injection.  Per patient, no other systemic side effects.
acute kidney injury (now chronic) due to receiving his 2nd dose of the Pfizer vaccine; This is a spontaneous report from a contactable consumer.  A consumer (patient's parent) reported that a 20-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number unknown), dose 2 via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. The consumer reported that the patient suffered acute kidney injury (now chronic) due to receiving his 2nd dose of the Pfizer vaccine. He used to be able to play basketball and run around the block without having to worry about his kidneys. He can now do neither simply because he wanted to protect himself and others. The outcome of the event was not recovered.    The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Pt. received MMR, Varicella and FLUMIST on 10/17 during routine physical but was complaining of sore throat and not feeling well, afebrile, strep test negative. Had 2min ? febrile seizure that evening at home. Transported to ER. Temp 103 degrees on arrival.
Major swelling; redness; pain (injection site and entire arm); fever; immobility of arm - 1 week; upset stomach (day of injection); continued pain since vaccination date that worsens with activity; visible inflammation. Initial treatment: taradol shot (anti-inflammatory), 10 days antibiotics; over the counter anti-inflammatories; heat and ice; 1 year later - prescribed Z-PACK and prednisone (10 days) for localized inflammation at injection site.
Patient came to workplace clinic 12/17 @ 1215 saying she had a reaction to the COVID vaccination. She stated she took ibuprofen in the morning for the headache, however, rash was still present. N/V on 12/16 at night. Patient reported no throat swelling or SOB. Rash on injection site (left) arm and chest. Patient received Benadryl 50 mg po x 1 dose and Tylenol 500 mg po  x 1 dose. After Benadryl and Tylenol, patient felt better and was able to go back to work. recommended to go  home and rest.
Swelling and redness (L) arm. No fevers or body rashes. Pt was given Hib instead of HepB.
Patient received extra dose of Varicella vaccine accidently. Mother made aware through phone call by Provider and Nursing Director. Per mother child is stable, no changes, mother reports no symptoms at this time. Advised to give Tylenol PRN and monitor patient for any changes, if changes occur take child to Emergency room. RTC for Follow up.
Began to feel unwell 11/14/2021; Tested Positive for COVID 11/15/2021.
BLOOD CLOT IN HEART; SUSPECTED COVID-19 INFECTION; SUSPECTED CLINICAL VACCINATION FAILURE; This spontaneous report received from a consumer via social media concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient died from getting covid (suspected covid-19 infection and suspected clinical vaccination failure) and having a blood clot in heart. It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the suspected clinical vaccination failure was not reported. This report was serious (Death, and Other Medically Important Condition). This report was associated with product quality complaint (PQC).; Sender's Comments: V0.20210923766-covid-19 vaccine ad26.cov2.s -blood clot in heart, suspected Covid 19 infection. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).   20210923766-covid-19 vaccine ad26.cov2.s -suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS; Reported Cause(s) of Death: BLOOD CLOT IN HEART; SUSPECTED COVID-19 INFECTION